Program Committee Workshop Review Panel
Mayo Clinic, Scottsdale, AZ Fiona E. Craig, MD
Fiona E. Craig, MD Tracy I. George, MD
Lisa M. Rimsza, MD Hans Peter Horny , MD
Mayo Clinic, Rochester, MN Katalin Kelemen, MD, PhD
Rebecca L. King, MD Rebecca L. King, MD
Kaaren K. Reichard, MD Attilio Orazi, MD
Kathleen A. Meyers, BS Leticia Quintanilla-Fend, MD
  Kaaren K. Reichard, MD
  Sa A. Wang, MD


Case Submission Portal Open

Cases to be requested include: 

1. Challenging cases of eosinophilia (peripheral, bone marrow, or lymph node/tissue-based) falling into any of the following categories

  • Reactive disorders associated with eosinophilia mimicking chronic eosinophilic leukemia, including but not limited to: 
    • Drug, toxin, infectious, other hypersensitivity
  • Eosinophilia associated with non-myeloid, tissue-based neoplasms or non-neoplastic lymphoproliferations (Kimura disease,  B and T cell lymphomas, Hodgkin lymphoma, histiocytic neoplasms, non-hematologic malignancy)
  • Lymphocytic variant of hypereosinophilic syndrome (LV-HES) including challenging, nodal and tissue based T cell infiltrates
  • Idiopathic hypereosinophilic syndrome
  • Chronic eosinophilic leukemia, NOS
  • Genetic  aberrations associated with eosinophilia including but not limited to: 
    • Myeloid/lymphoid neoplasms associated with eosinophilia and PDGRFA, PDGFRB, FGFR1, and PCM1-JAK2
    • AML with inversion 16
  • Eosinophilia associated with other diseases aside from mastocytosis or those listed above (e.g., AML , ALL with t(5;14), myeloproliferative neoplasms, myelodysplastic syndrome, etc.)

Challenging cases of mastocytosis (with or without eosinophilia) including: 

  • Cutaneous mastocytosis
  • Systemic mastocytosis (including tissue- based and nodal mast cell infiltrates)
    • Indolent systemic mastocytosis
    • Smoldering systemic mastocytosis
    • Systemic mastocytosis with associated hematological neoplasm
    • Aggressive systemic mastocytosis           
    • Mast cell leukemia including chronic and aleukemic examples
    • Mast cell sarcoma 
  • Myelomastocytic leukemia

Entities with proliferations of cells that may mimic mast cells (including but not limited to acute promyelocytic leukemia, basophilic leukemia)‚Äč

The case submission portal is managed through ASCPedia. You will need an ASCP customer login or will need to create a new account before accessing the portal.

If you need instructions, please read the Case Submission Information




More information on Case Submissions

Contact: Melissa Lord-Toof, MBA, ASCP Manager of Affiliated Organizations, This email address is being protected from spambots. You need JavaScript enabled to view it.

Deadline February 6, 2019